MPs push for more details on VPAG and NICE threshold changes The House of Commons Science Innovation and Technology Committee has asked the government for further clarification on what investment it plans to make into the ‘Voluntary scheme for branded medicines pricing, access and growth’.…
From adviser to prescriber: pharmacy’s evolution within the cardiology healthcare team Embedding a prescribing pharmacist within a hospital cardiology multidisciplinary team represented a cultural shift but led to significant benefits for patients and the wider healthcare system.…
Top five articles from the Royal Pharmaceutical Society’s research journals As the year draws to a close, we look back at the most popular pharmacy practice, health services and pharmaceutical sciences research articles of 2025.…
Health news round-up: haematology, mental health and pharmacogenomics A weekly summary of important developments in health news that you may have missed.…
All patients should undergo pharmacogenetic testing before being prescribed clopidogrel The UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics has highlighted that a significant proportion of the UK population have lower CYP2C19 enzyme levels, which lower the effectiveness of the antiplatelet drug.…
Participation in commercial clinical trials falls for fourth year in a row, finds ABPI An Association of the British Pharmaceutical Industry report showed that although the number of trial participants increased, the proportion of people recruited to commercial trials was dropping.…
Collaboration to diversify trial participation through community pharmacies launched The National Pharmacy Association and the Centre for Research Equity have outlined plans to develop a network of research sites in community pharmacies to support inclusive participation in research.…
Managing patients with cardiorenal metabolic disease An overview of the pathophysiology of cardiorenal metabolic disease, medication optimisation strategies and the role of the pharmacist in medication management and patient education.…
RPS invites responses to pharmacogenomics prescribing consultation The Royal Pharmaceutical Society said that its draft pharmacogenomic resource offers reflections on how competencies taken from its ‘Competency framework for all prescribers’ apply to pharmacogenomics.…
How can the NHS make the most of the paediatric pharmacogenomics opportunity? Attendees at a roundtable hosted by The Pharmaceutical Journal discussed challenges around implementing pharmacogenomic prescribing in the NHS and particular considerations for paediatric patients.… Supported content
